https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-07-19 / Clin. Cancer Res. 2011 Sep;17(17):5725-35
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-07-19 / Clin. Cancer Res. 2011 Sep;17(17):5725-352011-07-19 00:00:002019-02-15 08:49:18Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-06-17 / J Clin Oncol 29: 2011 (suppl; abstr e13029)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-06-17 / J Clin Oncol 29: 2011 (suppl; abstr e13029)2011-06-17 11:41:282019-07-17 11:42:05Dendritic cell (DC) vaccination with low dose temozolomide phase I/II trial in melanoma patients: Preliminary data on peripheral blood regulatory t-cells (Treg) and DC-TEM8 expression modulations.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr e13084)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr e13084)2011-06-04 11:42:372019-07-17 11:43:10Melanoma patients treated with dendritic cell vaccination, interleukin-2, and metronomic cyclophosphamide: Results from a phase II trial.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-03-01 / Scand. J. Immunol. 2011 Mar;73(3):222-33
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-03-01 / Scand. J. Immunol. 2011 Mar;73(3):222-332011-03-01 00:00:002019-02-15 08:49:20Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-02-10 / Gene Ther. 2011 Jun;18(6):584-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-02-10 / Gene Ther. 2011 Jun;18(6):584-932011-02-10 00:00:002019-02-15 08:49:19Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-01 / Curr Opin Investig Drugs 2010 Dec;11(12):1399-408
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-01 / Curr Opin Investig Drugs 2010 Dec;11(12):1399-4082010-12-01 00:00:002019-02-15 08:49:21New approaches to the development of adenoviral dendritic cell vaccines in melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-11 / Cancer Immunol. Immunother. 2011 Feb;60(2):249-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-11 / Cancer Immunol. Immunother. 2011 Feb;60(2):249-602010-11-11 00:00:002019-02-15 08:49:22Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-20 / Cancer Immunol. Immunother. 2011 Jan;60(1):123-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-20 / Cancer Immunol. Immunother. 2011 Jan;60(1):123-312010-10-20 00:00:002019-02-15 08:49:23Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-01 / Cytotherapy 2010 Oct;12(6):721-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-01 / Cytotherapy 2010 Oct;12(6):721-342010-10-01 00:00:002019-02-15 08:49:25Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-27 / J Transl Med 2010 Sep;8:89
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-27 / J Transl Med 2010 Sep;8:892010-09-27 00:00:002019-02-15 08:49:23Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
